Champions Oncology Statistics
Total Valuation
CSBR has a market cap or net worth of $70.16 million. The enterprise value is $69.89 million.
| Market Cap | 70.16M |
| Enterprise Value | 69.89M |
Important Dates
The next confirmed earnings date is Thursday, September 10, 2026, after market close.
| Earnings Date | Sep 10, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
CSBR has 13.89 million shares outstanding. The number of shares has decreased by -3.05% in one year.
| Current Share Class | 13.89M |
| Shares Outstanding | 13.89M |
| Shares Change (YoY) | -3.05% |
| Shares Change (QoQ) | +0.19% |
| Owned by Insiders (%) | 26.38% |
| Owned by Institutions (%) | 12.89% |
| Float | 6.09M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.22 |
| Forward PS | 1.11 |
| PB Ratio | 18.40 |
| P/TBV Ratio | 20.12 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.22 |
| EV / EBITDA | 207.62 |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.96, with a Debt / Equity ratio of 1.13.
| Current Ratio | 0.96 |
| Quick Ratio | 0.91 |
| Debt / Equity | 1.13 |
| Debt / EBITDA | 2.16 |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -29.97% and return on invested capital (ROIC) is -34.05%.
| Return on Equity (ROE) | -29.97% |
| Return on Assets (ROA) | -2.17% |
| Return on Invested Capital (ROIC) | -34.05% |
| Return on Capital Employed (ROCE) | -14.56% |
| Weighted Average Cost of Capital (WACC) | 6.08% |
| Revenue Per Employee | $277,687 |
| Profits Per Employee | -$5,491 |
| Employee Count | 214 |
| Asset Turnover | 2.00 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, CSBR has paid $246,000 in taxes.
| Income Tax | 246,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -24.89% in the last 52 weeks. The beta is 0.40, so CSBR's price volatility has been lower than the market average.
| Beta (5Y) | 0.40 |
| 52-Week Price Change | -24.89% |
| 50-Day Moving Average | 5.51 |
| 200-Day Moving Average | 6.09 |
| Relative Strength Index (RSI) | 50.49 |
| Average Volume (20 Days) | 8,633 |
Short Selling Information
The latest short interest is 73,998, so 0.53% of the outstanding shares have been sold short.
| Short Interest | 73,998 |
| Short Previous Month | 76,164 |
| Short % of Shares Out | 0.53% |
| Short % of Float | 1.21% |
| Short Ratio (days to cover) | 6.51 |
Income Statement
In the last 12 months, CSBR had revenue of $59.43 million and -$1.18 million in losses. Loss per share was -$0.08.
| Revenue | 59.43M |
| Gross Profit | 28.53M |
| Operating Income | -1.03M |
| Pretax Income | -929,000 |
| Net Income | -1.18M |
| EBITDA | 348,000 |
| EBIT | -1.03M |
| Loss Per Share | -$0.08 |
Balance Sheet
The company has $4.87 million in cash and $4.60 million in debt, with a net cash position of $274,000 or $0.02 per share.
| Cash & Cash Equivalents | 4.87M |
| Total Debt | 4.60M |
| Net Cash | 274,000 |
| Net Cash Per Share | $0.02 |
| Equity (Book Value) | 4.07M |
| Book Value Per Share | 0.28 |
| Working Capital | -703,000 |
Cash Flow
In the last 12 months, operating cash flow was -$4.47 million and capital expenditures -$564,000, giving a free cash flow of -$5.04 million.
| Operating Cash Flow | -4.47M |
| Capital Expenditures | -564,000 |
| Depreciation & Amortization | 1.38M |
| Net Borrowing | -135,000 |
| Free Cash Flow | -5.04M |
| FCF Per Share | -$0.36 |
Margins
Gross margin is 48.00%, with operating and profit margins of -1.73% and -1.98%.
| Gross Margin | 48.00% |
| Operating Margin | -1.73% |
| Pretax Margin | -1.56% |
| Profit Margin | -1.98% |
| EBITDA Margin | 0.59% |
| EBIT Margin | -1.73% |
| FCF Margin | n/a |
Dividends & Yields
CSBR does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 3.05% |
| Shareholder Yield | n/a |
| Earnings Yield | -1.62% |
| FCF Yield | -6.94% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | 9.27% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on August 12, 2015. It was a reverse split with a ratio of 1:12.
| Last Split Date | Aug 12, 2015 |
| Split Type | Reverse |
| Split Ratio | 1:12 |
Scores
CSBR has an Altman Z-Score of 0.23 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.23 |
| Piotroski F-Score | 2 |